Pseudomonas aeruginosa Biofilms

Minh Tam Tran Thi1, David Wibowo1, Bernd H A Rehm1

  • 1Centre for Cell Factories and Biopolymers, Griffith Institute for Drug Discovery, Griffith University, Nathan, QLD 4111, Australia.

Insights

Pseudomonas aeruginosa forms antibiotic-resistant biofilms, enabling persistent infections in healthcare settings. This review explores biofilm development, molecular mechanisms, and novel therapeutic strategies for combating these challenging infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biotechnology

Background:

  • Pseudomonas aeruginosa is an opportunistic pathogen causing severe infections, particularly in immunocompromised individuals.
  • Its persistence is linked to antibiotic-resistant biofilm formation, a complex structure protecting bacteria from environmental stresses and host defenses.
  • Biofilms facilitate colonization and long-term persistence, posing significant challenges in clinical settings.

Purpose of the Study:

  • To review current knowledge on Pseudomonas aeruginosa biofilms, including their development and molecular mechanisms of persistence.
  • To discuss explosive cell lysis within biofilms and interspecies interactions with Streptococcus.
  • To investigate recent advancements in diagnostics and therapeutic strategies for P. aeruginosa biofilm infections.

Main Methods:

  • Literature review of scientific articles and research papers on Pseudomonas aeruginosa biofilms.
  • Analysis of molecular mechanisms underlying biofilm formation, invasion, and persistence.
  • Compilation and evaluation of current diagnostic and therapeutic approaches.

Main Results:

  • Biofilms provide a protective scaffold through extracellular polymeric substances, enhancing bacterial survival and colonization.
  • Cell lysis within biofilms contributes essential materials for biofilm structure and community function.
  • Interspecies biofilms with Streptococcus may reduce P. aeruginosa virulence, potentially improving disease outcomes.

Conclusions:

  • Understanding P. aeruginosa biofilm dynamics is crucial for developing effective treatments.
  • Novel diagnostic tools and therapeutic strategies targeting biofilms are essential for combating persistent infections.
  • Further research into interspecies interactions and biofilm matrix components holds promise for future interventions.